---
figid: PMC4057680__ijms-15-07409f2
figlink: /pmc/articles/PMC4057680/figure/f2-ijms-15-07409/
number: Figure 2
caption: Schematic illustration of LDH-FITC nanoparticle intracellular fate. (A) TEM
  image of LDH-FITC nanoparticles; (B) CHO cells transfected with LDH-FITC nanoparticles;
  (C) Pumping protons into the endosome to facilitate acidification for subsequent
  proteolysis of nutrients, followed by an influx of chloride ions; (D) Acid-driven
  dissolution of LDH-FITC nanoparticles in the late endosome to buffer acidification
  and ions were released; (E) Entrance of water molecules to the endosome due to an
  increase in ionic strength, leading to osmotic swelling and endosome burst, which
  releases LDH-FITC nanoparticles into the cytoplasm. Step I. Adhesion of LDH-FITC
  nanoparticles to the cell membrane; II. Clathrin-mediated endocytosis; III. Endosomal
  changes; IV. Nuclear localization of LDH-FITC; V. Cytoplasmic distribution of LDH-FITC;
  VI. Lysosomal pathway; VII. Unspecific uptake through macropinocytosis; VIII–IX.
  Caveolae-mediated endocytosis; X. Microtubule directing thefreed LDH-FITC nanoparticles
  to the nucleus. (Cited with permission from Xu et al. [].)
pmcid: PMC4057680
papertitle: Potential for Layered Double Hydroxides-Based, Innovative Drug Delivery
  Systems.
reftext: Kai Zhang, et al. Int J Mol Sci. 2014 May;15(5):7409-7428.
pmc_ranked_result_index: '161660'
pathway_score: 0.8372635
filename: ijms-15-07409f2.jpg
figtitle: LDH-FITC nanoparticle intracellular fate
year: '2014'
organisms: Homo sapiens
ndex: 0e1a53ea-de8e-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4057680__ijms-15-07409f2.html
  '@type': Dataset
  description: Schematic illustration of LDH-FITC nanoparticle intracellular fate.
    (A) TEM image of LDH-FITC nanoparticles; (B) CHO cells transfected with LDH-FITC
    nanoparticles; (C) Pumping protons into the endosome to facilitate acidification
    for subsequent proteolysis of nutrients, followed by an influx of chloride ions;
    (D) Acid-driven dissolution of LDH-FITC nanoparticles in the late endosome to
    buffer acidification and ions were released; (E) Entrance of water molecules to
    the endosome due to an increase in ionic strength, leading to osmotic swelling
    and endosome burst, which releases LDH-FITC nanoparticles into the cytoplasm.
    Step I. Adhesion of LDH-FITC nanoparticles to the cell membrane; II. Clathrin-mediated
    endocytosis; III. Endosomal changes; IV. Nuclear localization of LDH-FITC; V.
    Cytoplasmic distribution of LDH-FITC; VI. Lysosomal pathway; VII. Unspecific uptake
    through macropinocytosis; VIII–IX. Caveolae-mediated endocytosis; X. Microtubule
    directing thefreed LDH-FITC nanoparticles to the nucleus. (Cited with permission
    from Xu et al. [].)
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ADCY1
  - LDHC
  - ADHFE1
  - CLTC
  - CLTA
  - ADH5
  - ADH7
  - ADCY5
  - ADH1A
  - CLTB
  - ADCY8
  - ADH4
  - ADCY2
  - LDHB
  - ADCY7
  - ADH6
  - ADH1B
  - ADCY6
  - ADCY3
  - ADH1C
  - ADCY10
  - LDHA
  - ADCY4
  - ADCY9
genes:
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY1
  entrez: '107'
- word: LDH
  symbol: LDH
  source: bioentities_symbol
  hgnc_symbol: LDHC
  entrez: '3948'
- word: ADH
  symbol: ADH
  source: bioentities_symbol
  hgnc_symbol: ADHFE1
  entrez: '137872'
- word: clathrin-
  symbol: Clathrin
  source: bioentities_symbol
  hgnc_symbol: CLTC
  entrez: '1213'
- word: clathrin-
  symbol: Clathrin
  source: bioentities_symbol
  hgnc_symbol: CLTA
  entrez: '1211'
- word: ADH
  symbol: ADH
  source: bioentities_symbol
  hgnc_symbol: ADH5
  entrez: '128'
- word: ADH
  symbol: ADH
  source: bioentities_symbol
  hgnc_symbol: ADH7
  entrez: '131'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY5
  entrez: '111'
- word: ADH
  symbol: ADH
  source: bioentities_symbol
  hgnc_symbol: ADH1A
  entrez: '124'
- word: clathrin-
  symbol: Clathrin
  source: bioentities_symbol
  hgnc_symbol: CLTB
  entrez: '1212'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY8
  entrez: '114'
- word: ADH
  symbol: ADH
  source: bioentities_symbol
  hgnc_symbol: ADH4
  entrez: '127'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY2
  entrez: '108'
- word: LDH
  symbol: LDH
  source: bioentities_symbol
  hgnc_symbol: LDHB
  entrez: '3945'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY7
  entrez: '113'
- word: ADH
  symbol: ADH
  source: bioentities_symbol
  hgnc_symbol: ADH6
  entrez: '130'
- word: ADH
  symbol: ADH
  source: bioentities_symbol
  hgnc_symbol: ADH1B
  entrez: '125'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY6
  entrez: '112'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY3
  entrez: '109'
- word: ADH
  symbol: ADH
  source: bioentities_symbol
  hgnc_symbol: ADH1C
  entrez: '126'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY10
  entrez: '55811'
- word: LDH
  symbol: LDH
  source: bioentities_symbol
  hgnc_symbol: LDHA
  entrez: '3939'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY4
  entrez: '196883'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY9
  entrez: '115'
chemicals: []
diseases: []
---
